Shuning Xu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Advanced Image Processing Techniques
Papers in
-
- Advanced Image Processing Techniques 6
- Advanced Vision and Imaging 4
- Image Enhancement Techniques 4
- Visual Attention and Saliency Detection 3
-
- Gastric Cancer Management and Outcomes 8
- Co-authors
- Ying Liu (5 shared papers)Lei Qiao (7 shared papers)Ke Li (2 shared papers)Jufeng Wang (2 shared papers)Yi Wang (6 shared papers)Fei Ma (7 shared papers)Ying Liu (1 shared paper)Xinfang Hou (2 shared papers)
In The Last Decade
Shuning Xu
49 papers receiving 540 citations
Peers
Comparison fields: 5 of 106
- Cancer Research 73
- Computer Vision and Pattern Recognition 67
- Soil Science 28
- Pulmonary and Respiratory Medicine 85
- Hepatology 19
Countries citing papers authored by Shuning Xu
This map shows the geographic impact of Shuning Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuning Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuning Xu more than expected).
Fields of papers citing papers by Shuning Xu
This network shows the impact of papers produced by Shuning Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuning Xu. The network helps show where Shuning Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuning Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells. | 2015 | 53 |
| 2 | Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer. | 2016 | 52 |
| 3 | 2020 | 47 | |
| 4 | 2023 | 39 | |
| 5 | 2023 | 34 | |
| 6 | 2015 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2018 | 23 | |
| 9 | 2022 | 18 | |
| 10 | 2023 | 16 | |
| 11 | 2024 | 15 | |
| 12 | 2024 | 15 | |
| 13 | 2024 | 15 | |
| 14 | 2018 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2023 | 11 | |
| 17 | 2022 | 10 | |
| 18 | 2015 | 9 | |
| 19 | 2021 | 9 | |
| 20 | 2019 | 9 |
About Shuning Xu
Shuning Xu is a scholar working on Computer Vision and Pattern Recognition, Pulmonary and Respiratory Medicine, Cancer Research, Media Technology and Human-Computer Interaction, having authored 55 papers that have together received 568 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (8 papers), Advanced Image Processing Techniques (6 papers), Advanced Vision and Imaging (4 papers), Image Enhancement Techniques (4 papers), RNA modifications and cancer (3 papers), Visual Attention and Saliency Detection (3 papers), Advanced Image Fusion Techniques (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Cancer Research (73 citations), Computer Vision and Pattern Recognition (67 citations), Soil Science (28 citations), Pulmonary and Respiratory Medicine (85 citations) and Hepatology (19 citations). Shuning Xu has collaborated with scholars based in China, Macao and Australia. Frequent co-authors include Ying Liu, Lei Qiao, Ke Li, Jufeng Wang, Yi Wang, Fei Ma, Ying Liu, Xinfang Hou, Shuai Li and Ke Li. Their work appears in journals such as Frontiers in Immunology, European Radiology, Abdominal Radiology, Frontiers in Oncology and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.